Clinical trial
Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes
NCT02317484 is registered in ClinicalTrials.gov with Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes
- Lead sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- February 28, 2018
- Enrollment
- 231 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.